Imexpharm Corporation (HOSE:IMP)
Vietnam · Delayed Price · Currency is VND 54,000
-100 (-0.18%)
At close: Feb 9, 2026
Imexpharm Revenue
In the year 2025, Imexpharm had annual revenue of 2.44T VND with 10.70% growth. Imexpharm had revenue of 640.78B in the quarter ending December 31, 2025, a decrease of -1.73%.
Revenue
2.44T
Revenue Growth
+10.70%
P/S Ratio
3.41
Revenue / Employee
1.68B
Employees
1,456
Market Cap
8.32T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.44T | 235.97B | 10.70% |
| Dec 31, 2024 | 2.21T | 211.08B | 10.59% |
| Jan 1, 2024 | 1.99T | 350.33B | 21.31% |
| Dec 31, 2022 | 1.64T | 377.11B | 29.77% |
| Dec 31, 2021 | 1.27T | -102.83B | -7.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DHG Pharmaceutical JSC | 4.98T |
| Traphaco JSC | 2.65T |
| Ha Tay Pharmaceutical JSC | 2.40T |
| Domesco Medical Import - Export Joint-Stock | 2.08T |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1.87T |
| Cuu Long Pharmaceutical JSC | 1.32T |
| OPC Pharmaceutical JSC | 1.06T |
| Vidipha Central Pharmaceutical JSC | 950.89B |